Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 42Carcinoma, Non-Small-Cell Lung 18Neoplasms 15Neoplasm Metastasis 14Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 8Ovarian Neoplasms 6Colorectal Neoplasms 6Uveal Melanoma 5Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Mesothelioma 5Diabetes Mellitus, Insulin-Dependent, 12 5Carcinoma, Transitional Cell 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Lung Neoplasms 4Carcinoma, Merkel Cell 4Advanced Cancer 4Uterine Cervical Neoplasms 3Stomach Neoplasms 3Prostatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Liver Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Carcinoma 3

Interventions

pembrolizumab 3Docetaxel 3Cisplatin 3Erlotinib Hydrochloride 2Cetuximab 2Carboplatin 2spartalizumab 1ixabepilone 1entrectinib 1Vorinostat 1Tablets 1Radiotherapy 1Radiosurgery 1RC48 antibody 1Paclitaxel 1Nivolumab 1NVP-BKM120 1Ipilimumab 1Gemcitabine 1Fluorodeoxyglucose F18 1FPP(RGD)2 1Everolimus 1Epirubicin 1Combined Modality Therapy 1Chemoprevention 1Capecitabine 1CTLA-4 Antigen 1Bevacizumab 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Salivary Gland Neoplasms × Ipilimumab × Clear all
NCT03749460 2023-12-29

Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

University of Washington

Phase 1/2 Completed
20 enrolled 12 charts
Head & Neck

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡